The University at Buffalo School of Pharmacy and Pharmaceutical Sciences has its own resident expert in the fields of ...
The approval was based on a comprehensive clinical data package, which included a single phase 1 trial and a phase 3 trial.
WILMINGTON, DE — NiKang Therapeutics® Inc. has achieved a pivotal step in the development of its first-in-class CDK2 degrader ...
Clinical Trials Arena on MSN4d
SRC approves opening of TransCode’s fourth cohort in trial of TTX-MC138A US Safety Review Committee (SRC) has granted unanimous approval for TransCode Therapeutics to open the fourth cohort in its ...
The FDA approved Stoboclo and Osenvelt, denosumab biosimilars that could offer more affordable treatment options for ...
today announced the positive results from the Company's pilot nonclinical pharmacokinetic (PK) study for its new generation levodopa/carbidopa asset for Parkinson's disease (PD), LXM.5. The ...
Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved STOBOCLO® (CT-P41, denosumab-bmwo) and OSENVELT® (CT-P41, denosumab-bmwo), biosimilars referencing PROLIA® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback